Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
Titel:
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
Auteur:
Konstantinopoulos, Panagiotis A Cheng, Su-Chun Wahner Hendrickson, Andrea E Penson, Richard T Schumer, Susan T Doyle, L Austin Lee, Elizabeth K Kohn, Elise C Duska, Linda R Crispens, Marta A Olawaiye, Alexander B Winer, Ira S Barroilhet, Lisa M Fu, Siqing McHale, Michael T Schilder, Russell J Färkkilä, Anniina Chowdhury, Dipanjan Curtis, Jennifer Quinn, Roxanne S Bowes, Brittany D'Andrea, Alan D Shapiro, Geoffrey I Matulonis, Ursula A